MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trifiletti, R. R.
Right arrow Articles by Snyder, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trifiletti, R. R.
Right arrow Articles by Snyder, S. H.

Kinetic differences between type I and type II benzodiazepine receptors

RR Trifiletti, MM Lo and SH Snyder

The kinetic properties of [3H]flunitrazepam [( 3H]FNZ) binding to central benzodiazepine receptors of bovine brain membranes at 0 degrees have been studied. Both dissociation and association (under pseudo- first order conditions) kinetics are biphasic, enabling definition of "fast" and "slow" compartments for both processes. In four brain regions examined, the proportion of receptor in the rapidly associating and rapidly dissociating compartments correlates with the proportion of Type I benzodiazepine receptor as determined from equilibrium radioligand binding studies in the four brain regions examined. Preincubation with the Type I-selective drugs CL-218,872 or methyl-beta- carboline-3-carboxylate (Ro 22-7497) reduces the size of the fast but not the slow kinetic compartments. Potencies of the drugs in eliciting these alterations in [3H]FNZ kinetics correlate with their potencies in displacing [3H]FNZ from Type I benzodiazepine receptors. Thus, in membrane preparations the more rapidly associating and dissociating site appears to represent the pharmacologically defined Type I benzodiazepine receptor, whereas the Type II receptors display slower association and dissociation kinetics. Soluble Type I receptors also display more rapid dissociation and association kinetics than soluble Type II receptors.

Volume 26, Issue 2, pp. 228-240, 09/01/1984
Copyright © 1984 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1984 by the American Society for Pharmacology and Experimental Therapeutics